The take-over rumors are rumbling on Boston Scientific's drop in share price. But if I were Johnson and Johnson (JNJ), who would I want, a stock that has been pummeled and continues w/massive debt, or a company with about the the same market cap that has had a steady record of growth over the past year?
Decisions, decisions.
-Wes
1 comment:
if you were jnj and acquired st jude, would you divest carto or esi?
Post a Comment